Additional findings included MEF2B positivity, confirming the lymphoma diagnosis, and an immunoglobulin gene rearrangement, which demonstrated a monoclonal B-cell population consistent with a neoplastic process. The gene discussed is MEF2B; the disease is lymphoma.